Endpoints Weekly reports on iECURE's gene therapy success for OTC deficiency, FDA CDER director Patrizia Cavazzoni's departure, and Verdiva Bio's $411M launch with Sciwind assets.
Hosted on MSN18h
FDA CDER director Patrizia Cavazzoni announces resignationFollowing a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback